Systemic therapy for gallbladder cancer in the era of precision medicine:Coexistence of opportunities and challenges

ZHANG Rui,GENG Zhimin

DOI: https://doi.org/10.3969/j.issn.1001-5256.2023.09.005

2023-01-01

Abstract:Gallbladder cancer is the most common malignant tumor of the biliary system，and its treatment outcome is greatly limited by its invasiveness and insensitivity to conventional radiotherapy and chemotherapy. In recent years，the emergence of various high－throughput sequencing techniques has helped to deepen the understanding of the molecular mechanisms of gallbladder cancer，and promising therapeutic targets have been identified and studied in clinical trials at present. A comprehensive exploration of the molecular subtypes of gallbladder cancer is of great importance for developing individualized diagnosis and treatment strategies. Several molecular subtyping systems have been proposed based on multi－omics features，which enhances the comprehension of the molecular mechanisms and features of gallbladder cancer among clinical researchers. With reference to the latest research advances in gallbladder cancer，this article investigates the challenges in the mutation targets and molecular subtyping of gallbladder cancer，analyzes the novel targets for targeted therapy and immunotherapy，and proposes new ideas for the precise diagnosis and individualized treatment of gallbladder cancer.